Work

Supplementary Table from Converting Tumoral PD-L1 into a 4-1BB Agonist for Safer and More Effective Cancer Immunotherapy

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Table from Converting Tumoral PD-L1 into a 4-1BB Agonist for Safer and More Effective Cancer Immunotherapy

DOI: 10.1158/2159-8290.22541231.v1

Authors: Zihai Li, Joseph H. Azar, Mark P. Rubinstein

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362555871

Cites:

Cited by:

Related to: 10